Laboratory studies of lyticase (enzymatic drug) as an antimycotic agent were carried out. The enzyme reduced optical density of Candida albicans test culture, inhibited adhesion of yeast-like fungi on vaginal epitheliocytes, stimulated the formation of germinative tubes, and made Candida albicans more available for phagocytosis.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
V. N. Prilepskaya and G. R. Bairamova, Rus. Med. Zh., 6, No. 5, 301–308 (2005).
A Method for Evaluation of Phagocytic Activity of Peripheral Blood Neutrophils in Living Organisms, Description of Invention for Patent of the Russian Federation. Registration No. of application: 2003107776/15 of 20.12.2004.
P. Ferrer, Microb. Cell Fact., 5, 10 (2006).
F. M. Klis, Yeast, 10, No. 7, 851–869 (1994).
K. Saeki, J. Iwata, S. Yamazaki, et al., J. Ferment. Bioeng., 78, 407–412 (2005).
A. M. Ventom and J. A. Asenjo, Enzyme Microb. Technol., 13, 71–75 (2007).
Author information
Authors and Affiliations
Corresponding author
Additional information
Translated from Byulleten’ Eksperimental’noi Biologii i Meditsiny, Vol. 148, No. 8, pp. 180–183, August, 2009
Rights and permissions
About this article
Cite this article
Sachivkina, N.P., Kravtsov, E.G., Vasilyeva, E.A. et al. Study of Antimycotic Activity of Lyticase. Bull Exp Biol Med 148, 214–216 (2009). https://doi.org/10.1007/s10517-009-0665-1
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10517-009-0665-1